Mental health correlates of drug treatment among women who use methamphetamine.
Mental health correlates of drug treatment among women who use methamphetamine.
复制标题
使用甲基苯丙胺的女性的心理健康与药物治疗相关。
DOI：
10.1111/ajad.12279
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
Lorvick,Jennifer
中科院分区：
文献类型：
--
作者：
Rade,CandalynB;Desmarais,SarahL;VanDorn,RichardA;Lutnick,Alexandra;Kral,AlexH;Lorvick,Jennifer
Background and ObjectivesWomen comprise over one‐third of people who use methamphetamine in the United States and have a higher prevalence of negative mental health consequences of methamphetamine use than men. Yet, few studies have investigated the mental health correlates of drug treatment among this population. We examined the relationship between mental disorders, mental health treatment, and drug treatment among women who use methamphetamine.MethodsWe used respondent‐driven sampling to recruit women who use methamphetamine (N= 322) for a survey about mental disorders, mental health treatment, drug use and treatment, and sociodemographic factors. Bivariate and multivariable logistic regression analyses were conducted.ResultsBivariate analyses indicated that race/ethnicity, mental health treatment, and presence and number of mental disorders were associated with drug treatment. Multivariable analyses revealed that women who reported mental health treatment during a 6‐month period had almost twice the odds of also reporting drug treatment than other women (AOR = 1.90; 95% CI = 1.11, 3.25), after controlling for mental disorders and race/ethnicity.ConclusionAmong women who use methamphetamine, participation in one service system (mental health treatment) is a key factor in increasing the odds of participation in another service system (drug treatment). Further research should establish the temporal association between mental health and drug treatment.Scientific SignificanceThe present study demonstrates the association between mental health treatment and drug treatment, above and beyond presence or number of mental disorders, and provides direction for drug treatment providers seeking to improve treatment entry and participation among women who use methamphetamine. (Am J Addict 2015;XX:1–8)
